DESCRIPTION: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients). METHODS: The KDIGO Lipid Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through August 2011 and supplemented by targeted searches through June 2013. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders. RECOMMENDATIONS: The full guideline includes 13 recommendations; a key element was the recommendation for statin or statin with ezetimibe treatment of adults aged 50 years or older with estimated glomerular filtration rates less than 60 mL/min/1.73 m2 but not treated with long-term dialysis or kidney transplantation. This synopsis focuses on 8 recommendations pertinent to assessment of lipid status and treatment with a statin-based regimen in adults.
DESCRIPTION: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients). METHODS: The KDIGO Lipid Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through August 2011 and supplemented by targeted searches through June 2013. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders. RECOMMENDATIONS: The full guideline includes 13 recommendations; a key element was the recommendation for statin or statin with ezetimibe treatment of adults aged 50 years or older with estimated glomerular filtration rates less than 60 mL/min/1.73 m2 but not treated with long-term dialysis or kidney transplantation. This synopsis focuses on 8 recommendations pertinent to assessment of lipid status and treatment with a statin-based regimen in adults.
Authors: Gema Ruiz-Hurtado; Pantelis Sarafidis; María S Fernández-Alfonso; Bernard Waeber; Luis M Ruilope Journal: Nat Rev Cardiol Date: 2016-04-07 Impact factor: 32.419
Authors: Marcio S Bittencourt; Edward A Hulten; Brian Ghoshhajra; Suhny Abbara; Venkatesh L Murthy; Sanjay Divakaran; Khurram Nasir; Luis Henrique W Gowdak; Leonardo V Riella; Marco Chiumiento; Udo Hoffmann; Marcelo F Di Carli; Ron Blankstein Journal: Kidney Int Date: 2015-01-28 Impact factor: 10.612
Authors: Gerald Klose; Frank Ulrich Beil; Hans Dieplinger; Arnold von Eckardstein; Bernhard Föger; Ioanna Gouni-Berthold; Franz Heigl; Wolfgang Koenig; Gert M Kostner; Ulf Landmesser; Ulrich Laufs; Frank Leistikow; Winfried März; Georg Noll; Klaus G Parhofer; Bernhard Paulweber; Walter F Riesen; Jürgen R Schaefer; Elisabeth Steinhagen-Thiessen; Armin Steinmetz; Hermann Toplak; Christoph Wanner; Eberhard Windler Journal: Wien Klin Wochenschr Date: 2014-03-11 Impact factor: 1.704
Authors: G Klose; F U Beil; H Dieplinger; A von Eckardstein; B Föger; I Gouni-Berthold; W Koenig; G M Kostner; U Landmesser; U Laufs; F Leistikow; W März; M Merkel; D Müller-Wieland; G Noll; K G Parhofer; B Paulweber; W Riesen; J R Schaefer; E Steinhagen-Thiessen; A Steinmetz; H Toplak; C Wanner; E Windler Journal: Internist (Berl) Date: 2014-05 Impact factor: 0.743